Alvotech ALVO
NASDAQ ALVO
$5.19 +0.00 (+0.00%)
As of: Sep 9, 2026 · 2:56 PM EDT

Alvotech (ALVO) Income from Non-Controlling Interests (2024 - 2026)

Alvotech's (ALVO) quarterly Income from Non-Controlling Interests came in at $660.7 million in Q1 2026, down 66.82% quarter-over-quarter from $2.0 billion in Q4 2025.

Analysis

Alvotech (ALVO) Income from Non-Controlling Interests (2024 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Income from Non-Controlling Interests for 3 consecutive years, with $660.7 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Income from Non-Controlling Interests changed N/A year-over-year to $660.7 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 billion (changed N/A YoY), and the FY2024 full-year result was -$3.0 million, changed N/A from the prior year.
  • Income from Non-Controlling Interests fell to $660.7 million in Q1 2026 per ALVO's latest filing, from $2.0 billion in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $2.0 billion in Q4 2025 and bottomed at -$3.0 million in Q4 2024.
  • Historically, Income from Non-Controlling Interests has averaged $661.5 million across 3 years, with a median of $328.9 million in 2024.
  • The widest YoY moves for Income from Non-Controlling Interests: up 67142.63% in 2025, down 67142.63% in 2025.
  • Over 3 years, Income from Non-Controlling Interests stood at -$3.0 million in 2024, then jumped by 67142.63% to $2.0 billion in 2025, then tumbled by 66.82% to $660.7 million in 2026.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $660.7 million, $2.0 billion, and -$3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Teva Pharmaceutical Industries 42.53 Bn 38.88 Bn 2.15 Bn -
2 Viatris 19.17 Bn 18.28 Bn 1.46 Bn -
3 Dr Reddys Laboratories 9.88 Bn 9.71 Bn 396.53 Mn -918,959.97
4 Amneal Pharmaceuticals 5.47 Bn 5.34 Bn 334.51 Mn 11.95 Mn
5 Bausch Health Companies 2.33 Bn 494.50 Mn 2.10 Bn 2.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -
8 Amphastar Pharmaceuticals 994.21 Mn 704.09 Mn 93.47 Mn -
9 Fennec Pharmaceuticals 400.89 Mn 359.65 Mn 17.15 Mn -
10 RedHill Biopharma 176.59 Mn 176.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 660.69 Mn
Dec 31, 2025 1.99 Bn
Sep 30, 2025 -2.97 Mn
Dec 31, 2024 -2.97 Mn